T1	Participants 49 96	during prescription opioid dependence treatment
T2	Participants 292 321	prescription opioid addiction
T3	Participants 676 709	multi-site clinical trial (N=353)
T4	Participants 1548 1594	individuals with prescription opioid addiction
